To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support access to Enhertu for patients with secondary breast cancer.
The National Institute for Health and Care Excellence (NICE) makes independent, evidence-based recommendations for the National Health Service in England on whether new licensed medicines should be routinely funded for eligible patients based on an evalua...
Trastuzumab Deruxtecan